Logo
G

Galux

22 employees

Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Artificial Intelligence
Antibody Drug
Drug Design
Protein Drug
Drug Discovery
Chemical Drug
Professional Services
Large Molecule Drug
Enzyme Drug
Small Molecule Drug
Neural Network
Drug Development
Product Research
Medical
Machine Learning
Biological Drug

Date founded

2020

Funding rounds raised

Total raised

$4M

from 2 investors over 2 rounds

G

Galux raised $4M on December 16, 2021

Investors: DAYLI Partners and 카카오브레인 - Kakao Brain

FAQ